The University Medical Center Groningen (UMCG) is one of the largest hospitals in the Netherlands and has extensive experience in European Programmes. The UMCG welcomes the idea behind the European Competitiveness Fund (ECF) and its integration into the next Multiannual Financial Framework (MFF), together with the next Horizon Europe programme (FP10), as tangible evidence of the importance the Commission attaches to…
University Medical Center Groningen
Academic / research · Netherlands · EU Transparency Register 021901530468-42
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 163 think tanks and research institutions on this site, they rank #56 by legislative files engaged, a count of participation, not a measure of influence.
Declares membership of
- EIT Health - https://eithealth.eu/
- ERN EURACAN - https://euracan.eu/
- MetabERN - https://metab.ern-net.eu/
- ERKNet - https://www.erknet.org/
- ENLIGHT - https://enlight-eu.org/
- The Guild - https://www.the-guild.eu/
- Coimbra Group - https://www.coimbra-group.eu/
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Think tanks and research institutions
- Registered as
- University Medical Center Groningen/Academisch Ziekenhuis Groningen (UMCG)
- Head office
- Groningen, Netherlands
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track University in PolicySpeak: request access →
Work at University Medical Center Groningen? so we know who speaks for it.
Their record over time
University Medical Center Groningen filed 4 positions between 9 Sept 2025 and 12 Nov 2025, across 3 of the 665 legislative files tracked here, attaching a full position paper 1 time.
What they argued
Explicit inclusion of European Reference Networks (ERNs) in the ECF is vital for health competitiveness and rare disease care The current proposal for the European Competitiveness Fund (ECF), specifically Chapter V (Articles 36 and 37) on Health, biotech, agriculture and bioeconomy, aligns perfectly with the mission of European Reference Networks (ERNs).
The University Medical Center Groningen (UMCG) is a university hospital with strong clinical research and testing infrastructure, an active valorisation chain (TTO, spin-offs), and intensive public-private collaboration. From this position, we support a European Innovation Act (EIA) that removes practical bottlenecks for health innovation and accelerates the path from lab to clinic and market.
The University Medical Center Groningen (UMCG) welcomes the European Commissions initiative to prepare a legislative proposal for an ERA Act. With regard to the Call for Evidence: R&D investment target: UMCG supports achieving the 3% R&D investment target but emphasizes that this must not come at the expense of basic or clinical research, nor result in disproportionate emphasis on defense-related R&D.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put University Medical Center Groningen next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 67.
Is this your organization?
Everything on this page comes from University Medical Center Groningen’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.